Related Experiment Videos
Severe restrictive lung disease in systemic sclerosis
Arthritis and Rheumatism
|September 1, 1994
Summary
Black men with early systemic sclerosis (SSc) and cardiac involvement face higher risks of severe lung disease. Early pulmonary function monitoring is crucial for identifying patients who may benefit from new therapies.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by fibrosis, vascular abnormalities, and immune dysregulation.
- Restrictive lung disease is a common and serious complication of SSc, significantly contributing to morbidity and mortality.
- Identifying risk factors and progression patterns of severe restrictive lung disease in SSc is critical for patient management.
Purpose of the Study:
- To identify risk factors associated with the development of severe restrictive lung disease in patients with SSc.
- To determine the time of onset and rate of progression of lung function decline in SSc patients with severe restrictive lung disease.
Main Methods:
- Patients from the University of Pittsburgh Scleroderma Databank were categorized based on their lowest forced vital capacity (FVC) percentage predicted.
- Severe restrictive lung disease was defined as FVC < or = 50% predicted.
- Serial pulmonary function test (PFT) results were analyzed to assess the rate of lung volume loss over time in patients with severe disease.
Main Results:
- Of 890 SSc patients, 13% (n=116) had severe restrictive lung disease (FVC < or = 50% predicted).
- Black race, male sex, early disease stage, and cardiac involvement were significantly associated with severe restrictive lung disease.
- Rapid FVC decline (32% per year) was observed in the first two years of illness in patients with severe restrictive lung disease.
Conclusions:
- Black men with early SSc and cardiac involvement are at the highest risk for severe restrictive lung disease.
- Early and careful monitoring of pulmonary function is essential, particularly during the initial years of SSc, when lung function decline is most rapid.
- Disease subtype and specific autoantibodies did not differentiate between moderate and severe restrictive lung disease, highlighting the importance of clinical and demographic factors.